Hypoxia in the Diabetic Kidney Is Independent of Advanced Glycation End-Products

被引:6
|
作者
Nordquist, Lina [1 ]
Liss, Per [2 ]
Fasching, Angelica [1 ]
Hansell, Peter [1 ]
Palm, Fredrik [1 ,3 ]
机构
[1] Uppsala Univ, Biomed Ctr, Div Integrat Physiol, Dept Med Cell Biol, S-75123 Uppsala, Sweden
[2] Uppsala Univ, S-75123 Uppsala, Sweden
[3] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden
来源
基金
英国医学研究理事会;
关键词
NITRIC-OXIDE; GLOMERULAR HYPERFILTRATION; NEPHROPATHY; AMINOGUANIDINE; INHIBITION; OVEREXPRESSION;
D O I
10.1007/978-1-4614-4989-8_26
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Sustained hyperglycemia is closely associated with increased risk to develop nephropathy. We have previously reported alterations in the intrarenal oxygen metabolism already after the early onset of diabetes. Furthermore, formation of advanced glycation end-products (AGE) is postulated as a major contributor to diabetic nephropathy. We therefore investigated the possible relationship between altered oxygen metabolism and AGE in diabetic kidneys. Normoglycemic and streptozotocin-diabetic rats with and without chronic treatment with aminoguanidine (AGE inhibitor; 600 mg/kg bw/24 h in drinking water) or L-N-6-(1-Iminoethyl) lysine (L-NIL, iNOS inhibitor, 1 mg/kg bw/24 h in drinking water) were studied 2 weeks after induction of diabetes. Glomerular filtration rate (GFR) was estimated by inulin clearance, oxygen tension (pO(2)) and interstitial pH by microelectrodes and regional renal blood flow (RBF) by laser-Doppler. Histological changes were evaluated on fixed tissue. Glomerular hyperfiltration was unaffected by aminoguanidine, whereas L-NIL normalized GFR in diabetic rats. pO(2) and interstitial pH, but not RBF, were lower in both kidney cortex and medulla compared to control rats, but was unaffected by both chronic treatments. Urinary protein excretion was higher in diabetic rats and unaffected by L-NIL, whereas aminoguanidine paradoxically increased this parameter. Damage scores were similar in all groups.
引用
收藏
页码:185 / 193
页数:9
相关论文
共 50 条
  • [1] Advanced glycation end-products and the kidney
    Busch, Martin
    Franke, Sybille
    Ruester, Christiane
    Wolf, Gunter
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 (08) : 742 - 755
  • [2] Advanced glycation end-products in diabetic nephropathy
    Sugiyama, S
    Miyata, T
    Horie, K
    Iida, Y
    Tsuyuki, M
    Tanaka, H
    Maeda, K
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 : 91 - 94
  • [3] Advanced glycation end-products in diabetic nephropathy
    Friedman, EA
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 : 1 - 9
  • [4] Advanced Glycation End-Products and Diabetic Neuropathy of the Retina
    Oshitari, Toshiyuki
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [5] Advanced glycation end-products and the progress of diabetic vascular complications
    Jakus, V
    Rietbrock, N
    [J]. PHYSIOLOGICAL RESEARCH, 2004, 53 (02) : 131 - 142
  • [6] Assessment of advanced glycation end-products as a biomarker of diabetic outcomes
    Simo-Servat, Olga
    Planas, Alejandra
    Ciudin, Andreea
    Simo, Rafael
    Hernandez, Cristina
    [J]. ENDOCRINOLOGIA DIABETES Y NUTRICION, 2018, 65 (09): : 540 - 545
  • [7] Roles of advanced glycation end-products in the progression of diabetic nephropathy
    Makino, H
    Shikata, K
    Kushiro, M
    Hironaka, K
    Yamasaki, Y
    Sugimoto, H
    Ota, Z
    Araki, N
    Horiuchi, S
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 : 76 - 80
  • [8] Advanced glycation end-products: a review
    Singh, R
    Barden, A
    Mori, T
    Beilin, L
    [J]. DIABETOLOGIA, 2001, 44 (02) : 129 - 146
  • [9] Eucommia ulmoides Ameliorates Glucotoxicity by Suppressing Advanced Glycation End-Products in Diabetic Mice Kidney
    Do, Moon Ho
    Hur, Jinyoung
    Choi, Jiwon
    Kim, Mina
    Kim, Min Jung
    Kim, Yoonsook
    Ha, Sang Keun
    [J]. NUTRIENTS, 2018, 10 (03):
  • [10] Advanced glycation end-products and atherosclerosis
    Vlassara, H
    [J]. ANNALS OF MEDICINE, 1996, 28 (05) : 419 - 426